Merck

Yahoo Finance • 15 hours ago

PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem

The VanEck Pharmaceutical ETF(NASDAQ:PPH) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF(NYSEMKT:IXJ) offers a broader reach across the international medical industry including biotechnology and e... Full story

Yahoo Finance • yesterday

Merck Announces Third-Quarter 2026 Dividend

RAHWAY, N.J., May 26, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company’s common... Full story

Yahoo Finance • 2 days ago

Dow Gives Back Early Gains. Healthcare Stocks Are a Drag.

The Dow gave back its opening gains, with healthcare stocks a big drag. The blue-chip index was trading flat, while the S&P 500 was up 0.9%, and the Nasdaq rose 1.4%. UnitedHealth Group and Amgen, among the Dow's top five stocks, were down... Full story

Yahoo Finance • 2 days ago

Zifo, Pistoia Alliance, and Pharma Majors Launch Global IVP Assay Repository

Repository standardizes how biological assays are captured, shared, and reused Zifo worked collaboratively with regulatory authorities and Pistoia Alliance members Steering committee included representatives from AbbVie, Novartis, Merck an... Full story

Yahoo Finance • 2 days ago

Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors

Combining a potential best-in-class tissue factor-targeting ADC with anti-PD-1 therapy may enhance the anti-tumor activity of the combination due to the complementary nature of the two mechanisms Adcendo will sponsor the Phase 1b clinical... Full story

Yahoo Finance • 2 days ago

The 1 AI Stock I'd Put in a Time Capsule and Open in 2036

Key Points Absci uses generative AI to design protein drugs before they are tested in a lab. Partnerships with Merck and Owkin validate Absci's hybrid AI-wet-lab drug platform. Long-term upside with this ticker depends on clinical success... Full story

Yahoo Finance • 4 days ago

Merck Oncology Updates Spark Interest In Sacituzumab Tirumotecan And Valuation

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Merck (NYSE:MRK) reported positive Phase 3 results for its antibody drug conjugate sacituzumab tirumotecan in advanced endo... Full story

Yahoo Finance • 5 days ago

Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints

Merck & Co. Inc. (NYSE:MRK) is one of the best low risk stocks to buy in 2026. On May 18, Merck announced that its pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab tirumotecan (sac-TMT) met its dual primary endpoints of overall sur... Full story

Yahoo Finance • 5 days ago

Stock Market Today: S&P 500, Nasdaq Eye Weekly Gains As Dow Climbs 350 Points; Merck Jumps (Live Coverage)

Stock Market Today: The Dow Jones index rose Friday ahead of a key inflation survey. AMD stock rallied near record highs. Continue Reading... Full story

Yahoo Finance • 5 days ago

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index advancing 1.1% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 5 days ago

Stock Market Today: Dow Tops 50,000; Cadence Design Breaks Out (Live Coverage)

Stock Market Today: The Dow Jones index rose Friday ahead of a key inflation survey. AMD stock rallied near record highs. Continue Reading... Full story

Yahoo Finance • 5 days ago

Sector Update: Healthcare Stocks Gain Friday Afternoon

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index advancing 0.8% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is up +0.50%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.63%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.73%.  June E-mini S&P futures (ESM26) are up +0.47%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 5 days ago

US Equity Indexes Rise as Momentum Builds to Secure Iran Peace Agreement

US equity indexes rose as pressure on government bond yields eased and crude oil retreated from intr PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 6 days ago

Stock Market Today: Dow Charges Higher As These Stocks Soar Ahead Of SpaceX IPO Plans (Live Coverage)

Stock Market Today: The Dow Jones index rose Friday ahead of a key inflation survey. AMD stock rallied near record highs. Continue Reading... Full story

Yahoo Finance • 6 days ago

Stocks Supported by US-Iran Peace Deal Optimism

The S&P 500 Index ($SPX) (SPY) today is up +0.54%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.70%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.53%.  June E-mini S&P futures (ESM26) are up +0.50%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 6 days ago

Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer

Merck stock popped early Friday after European officials recommended approving its combination for a form of bladder cancer. Continue Reading... Full story

Yahoo Finance • 6 days ago

3 Stocks That May Be Trading Below Their Estimated Value In May 2026

The United States market has experienced a flat week but has shown significant growth over the past year with a 27% increase, and earnings are anticipated to grow by 17% annually. In this context, identifying stocks that may be trading bel... Full story

Yahoo Finance • 6 days ago

2 Reasons to Watch MRK and 1 to Stay Cautious

Merck has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.8%. The stock now trades at $113.99, marking a 20% gain. This was partly thanks to its solid quarterly results, and the performance may hav... Full story

Yahoo Finance • 6 days ago

Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)

WATERTOWN, Mass., May 21, 2026--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has received approval from the KRX to proceed... Full story